| Literature DB >> 32592691 |
E Ilker Ozay1, Sudarvili Shanthalingam2, Joe A Torres1, Barbara A Osborne3, Gregory N Tew4, Lisa M Minter5.
Abstract
T cell receptor signaling, together with cytokine-induced signals, can differentially regulate RNA processing to influence T helper versus regulatory T cell fate. Protein kinase C family members have been shown to function in alternative splicing and RNA processing in various cell types. T cell-specific protein kinase C theta, a molecular regulator of T cell receptor downstream signaling, has been shown to phosphorylate splicing factors and affect post-transcriptional control of T cell gene expression. In this study, we explored how using a synthetic cell-penetrating peptide mimic for intracellular anti-protein kinase C theta delivery fine-tunes differentiation of induced regulatory T cells through its differential effects on RNA processing. We identified protein kinase C theta signaling as a critical modulator of two key RNA regulatory factors, heterogeneous nuclear ribonucleoprotein L (hnRNPL) and protein-l-isoaspartate O-methyltransferase-1 (PCMT1), and loss of protein kinase C theta function initiated a "switch" in post-transcriptional organization in induced regulatory T cells. More interestingly, we discovered that protein-l-isoaspartate O- methyltransferase-1 acts as an instability factor in induced regulatory T cells, by methylating the forkhead box P3 (FOXP3) promoter. Targeting protein-l-isoaspartate O-methyltransferase-1 using a cell-penetrating antibody revealed an efficient means of modulating RNA processing to confer a stable regulatory T cell phenotype.Entities:
Keywords: FOXP3; PCMT1; PKCθ; alternative splicing; cell-penetrating peptide mimics; hnRNPL; induced regulatory T cell; intracellular antibody delivery
Year: 2020 PMID: 32592691 PMCID: PMC7544975 DOI: 10.1016/j.ymthe.2020.06.012
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454